About 800 reports

  • 2.2 Classification of Diabetes
  • B) US Diabetes market size

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes Summary Diabetes mellitus (DM) is a generalized term used to define multiple diseases with different etiologies that are characterized by chronic...

  • Diabetes
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • SYMPTOMS OF DIABETES
  • 1.1 DIABETES

Diabetes, referred to as diabetes mellitus by doctors, is a group of metabolic disorders which abnormally affect the level of sugar (glucose) in blood. Diabetes can either be due to pancreas not producing enough insulin or irresponsiveness of cells of the body to insulin. Insulin is a hormone which regulates the metabolism of...

  • Diabetes
  • United States
  • World
  • DexCom, Inc.
  • Johnson & Johnson
  • Diabetes Drugs Markets in China
  • Diabetes Drugs Capacity, Output and Demand and

China’s demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Diabetes
  • China
  • GSK China Inc.
  • Novo Nordisk Pharmaceutical Co., Ltd.
  • Zhejiang Expressway Co., Ltd.

Global Diabetes Diagnostics Industry DIABETES DIAGNOSTICS MCP-## A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS ##.

  • Diabetes
  • APAC
  • Japan
  • United States
  • World
  • Diabetes Drugs Imports
  • Diabetes Drugs Production and Demand

This study focuses on China’s Diabetes Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Antidiabetics
  • Diabetes
  • Insulin
  • China
  • Demand
  • Complications with Diabetes
  • Diabetes Pathophysiology

Diabetes is a chronic disease in which there are high levels of sugar in the blood. The World Diabetes Foundation estimates that there will be 438 million people with diabetes by the year 2030. Oral anti-diabetics were the leading category of drugs in 2014 and showed a growth rate of 6.3% from the total global sales. The total sales for insulin...

  • Diabetes
  • United States
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Takeda Pharmaceutical Company Limited

GLOBAL DIABETES DRUGS MARKET FORECAST 2018-2026 ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • World
  • Forecast
  • A) Global diabetes and obesity market
  • Diabetes an d obesity

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment Summary Diabetes mellitus refers to a group of metabolic diseases characterized by chronic hyperglycemia (high blood glucose levels) that results from defects in insulin...

  • Diabetes
  • World
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group

Glucagon-like peptide-## (GLP-##) agonist ##. ##. ##.

  • Chronic Disease
  • Diabetes
  • APAC
  • World
  • Forecast
  • By Diabetes - Population Segmentation
  • Russia: Forecast for Diabetes Population (Thousand), 2018 - 2024

Self-Monitoring Blood Glucose (SMBG) device market is providing big business opportunities for device manufactures in the Europe. It is projected that Europe Blood Glucose Device market will climb to nearly US$ 8 Billion landmark by the end of 2024. Driving factors which help to reach this market are increasing diabetic...

  • Diabetes
  • Northern Europe
  • Scandinavia
  • Western Europe
  • Forecast
  • Diabetes Drugs Industry Capacity
  • Diabetes Drugs Companies in China

This study focuses on China’s Diabetes Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...

  • Diabetes
  • China
  • Bayer AG
  • Beijing Taiyang Pharmaceutical Group
  • Eli Lilly & Co.
  • 32.1 France - Diabetes Population
  • 48.1 Canada Diabetes Population

Global CGM market is forecast to cross more than US$ 4 Billion by 2024. Continuous Glucose Monitoring (CGM) systems are the most recent innovation in diabetes management. In Contrast, to traditional systems that allow for one time check of glucose levels, a CGM device notifies the user if the glucose level nears current...

  • Chronic Disease
  • Diabetes
  • Diabetes Monitoring
  • Western Europe
  • Forecast
  • Parent market: Global diabetes therapeutics market 2017
  • PROPORTION OF PEOPLE AGED 20-79 WITH DIABETES 2015

About Non-insulin Diabetes Therapeutics Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels. Technavio’s analysts forecast the global non-insulin diabetes therapeutics market to grow at a CAGR of 11.37%...

  • Diabetes
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Sanofi S.A.

Global Markets for Diabetes Therapeutics and Diagnostics CHAPTER ## INTRODUCTION ## STUDY GOALS AND OBJECTIVES ## REASONS FOR DOING THE STUDY ## SCOPE OF REPORT ## MARKET ANALYSES AND FORECASTS ## METHODOLOGY ## INTENDED AUDIENCE ## INFORMATION SOURCES ## ANALYST' S CREDENTIALS ## RELATE

  • Chronic Disease
  • Diabetes
  • Pathology
  • World

Diabetes Injection Pens Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Chronic Disease
  • Diabetes
  • APAC
  • World
  • Demand

Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024 ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • World
  • Market Size

Glucagon-like peptide-## (GLP-##) receptor agonists ##. ##. ##. ##.

  • Diabetes
  • Therapy
  • APAC
  • World
  • Market Size

Europe DIABETES DRUGS MARKET FORECAST 2018-2026 ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • Europe
  • Forecast

Biomarkers Enabling Diabetes and Obesity Management ##. ##. ## EXECUTIVE SUMMARY ##. ## Executive Summary ##. ## Scope of Research ##. ## Research Methodology ##. ## Key Findings ##. ##. ## ROLE OF BIOMARKERS IN DIABETES AND OBESITY MANAGEMENT ##. ## Role of Biomarkers in Diabetes and

  • Biomarker
  • Diabetes
  • Genomics
  • World
  • Forecast

Asia Pacific DIABETES DRUGS MARKET FORECAST 2018-2026 ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • APAC
  • Forecast

ASIA-PACIFIC DIABETES DRUGS MARKET FORECAST 2018-2026 ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • APAC
  • Forecast

NORTH AMERICA DIABETES DRUGS MARKET FORECAST 2018-2026 ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • North America
  • Forecast

Obesity is believed to be one of the foremost factors leading to diabetes in individuals.

  • Chronic Disease
  • Diabetes
  • United States
  • Forecast
  • Market Size
  • Diabetes Prevalence
  • Diabetes Prevalence

Blood Glucose Test Strips Global Market Opportunities And Strategies By Technology: Glucose Dehydrogenase, Glucose Oxidase; By Electrode Material Use: Thick Film Electrochemical Films, Thin Film Electrochemical Films, Optical Strips; With Forecast Until 2021 The blood glucose test strips industry includes establishments...

  • Diabetes
  • World
  • Forecast
  • Market Size
  • Roche Group

Next Generation Diabetes Therapy and Drug Delivery Market - Global Opportunity Analysis and Industry Forecast, 2014-2023 CHAPTER ## INTRODUCTION ##. ##.

  • Diabetes
  • Therapy
  • APAC
  • World
  • Market Size
  • Diabetes Prevalence
  • Diabetes Prevalence

The blood glucose test strips industry includes establishments involved in manufacturing test strips used for blood sugar level measurement.Blood glucose test strips are thin paper or plastic strips which help to monitor blood glucose level and control diabetes symptoms. Test strips are generally used in medical devices...

  • Diabetes
  • World
  • Forecast
  • Market Size
  • Roche Group
  • Diabetes complications
  • MAJOR COMPLICATIONS OF DIABETES

About Coronary Artery Disease Therapeutics Coronary artery disease (CAD) is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries...

  • Diabetes
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • 13.1 AUSTRALIA DIABETES POPULATION & FORECAST
  • 11.1 GERMANY DIABETES POPULATION & FORECAST

Globally, insulin pump market is anticipated to cross US$ 8 Billion by 2024. The growth of diabetes management policy and expansion of diabetes knowledge over the world, the market for insulin pump will develop positive outlook in future year. With the assistance of insulin pump patients deal with their diabetes with a high level...

  • Diabetes
  • Western Europe
  • Forecast
  • Insulet Corporation
  • Medtronic, Inc.
  • Government Programs for Diabetes
  • Increasing Healthcare Expenditure on Diabetes

The insulin pumps market is estimated to account for US$ 8,264.01 Mn by the end of 2025, escalating at a CAGR of 10.5% during the forecast period from 2018 to 2025, rising from US$ 3,822.44 Mn in 2017. The increasing rise in the geriatric population is the significant factor that is expected to drive the growth of the global insulin pumps...

  • Diabetes
  • World
  • Forecast
  • Market Size
  • Insulet Corporation

Around three decades ago, less than one percent of the Chinese adult population had diabetes.

  • Chronic Disease
  • Diabetes
  • Pathology
  • China
  • Market Size